EP Patent

EP3299370B1 — Crystalline forms of diazabicyclooctane derivative and production process thereof

Assigned to Meiji Seika Pharma Co Ltd · Expires 2021-11-24 · 4y expired

What this patent protects

Patent listed against chembl-chembl1200962.

Drugs covered by this patent

chembl-chembl1200962 (CEFEPIME HYDROCHLORIDE)

Patent Metadata

Patent number: EP3299370B1
Jurisdiction: EP
Classification: —
Expires: 2021-11-24
Drug substance claim: No
Drug product claim: No
Assignee: Meiji Seika Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.